Janaina Bosso da Silva Ricciardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Janaina Bosso da Silva Ricciardi has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Margareth Castro Ozelo
Hemocentro UNICAMP, University of Campinas, Campinas, SP, Brazil
4 shared publications - Allan Oliveira Santos
Universidade Estadual de Campinas, Brazil
3 shared publications - Rodrigo Gonçalves Pagnano
Universidade Estadual de Campinas (UNICAMP)
3 shared publications - Glenda Feldberg
Hemophilia Treatment Center (HTC) “Cláudio Luiz Pizzigatti Corrêa” Hemocentro UNICAMP University of Campinas Campinas SP Brazil
2 shared publications - Alessandro Rozim Zorzi
Hospital Israelita Albert Einstein São Paulo SP Brazil Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
1 shared publication - Carolina Kosour
Universidade Federal de Alfenas
1 shared publication
Latest Publications
- Open Access
- 20 February 2026
- Published by Wiley in Haemophilia
- Vol. 32 (2) , 381-401
Exercise Programmes for People With Haemophilia: A Scoping Review
Background: Advances in haemophilia treatment have enabled safe exercise practice as recommended by disease management guidelines, yet there is no gold‐standard protocol for optimal dose. Emerging therapies could influence exercise recommendations, highlighting the need for evidence‐based guidelines tailored to people with haemophilia to ensure better safety and health outcomes. Aims: To provide an updated comprehensive mapping of the literature, exploring the modalities, frequency, duration and intensity of exercise programmes for PwH. Methods: A scoping review was conducted following JBI methodology and PRISMA‐ScR guidelines (PubMed, BVS, Scopus, Web of Science, EMBASE, Cochrane, PEDro, SPORTDiscus and grey literature). Inclusion criteria were defined using ‘PCC’ (population, concept and context), and the research question was ‘What modalities, duration, frequency and intensity are being utilised in exercise programmes for PwH in any context?’ Results: Out of 5.579 references, 36 studies were included, with 15 reported in a single source. Exercise frequency was mainly set at 3 days/week in primary studies, with a median of 2–4 days/week reported in systematic reviews. Training intensity was mainly defined by repetition maximum or maximum heart rate. Interventions generally lasted 6 weeks, with a median duration of 4–30 weeks in systematic reviews. Strengthening, flexibility, and aerobic exercise were the most common modalities, whereas endurance and proprioceptive training were rarely employed. Conclusions: Exercise dosages in this review align with current evidence for people with haemophilia, but individualised prescriptions remain critical to optimising health outcomes. Future research should prioritise standardised, evidence‐based protocols.
- 20 February 2026
- Published by Wiley in Haemophilia
- Vol. 32 (2) , 381-401
Open AccessExercise Programmes for People With Haemophilia: A Scoping Review
Background: Advances in haemophilia treatment have enabled safe exercise practice as recommended by disease management guidelines, yet there is no gold‐standard protocol for optimal dose. Emerging therapies could influence exercise recommendations, highlighting the need for evidence‐based guidelines tailored to people with haemophilia to ensure better safety and health outcomes. Aims: To provide an updated comprehensive mapping of the literature, exploring the modalities, frequency, duration and intensity of exercise programmes for PwH. Methods: A scoping review was conducted following JBI methodology and PRISMA‐ScR guidelines (PubMed, BVS, Scopus, Web of Science, EMBASE, Cochrane, PEDro, SPORTDiscus and grey literature). Inclusion criteria were defined using ‘PCC’ (population, concept and context), and the research question was ‘What modalities, duration, frequency and intensity are being utilised in exercise programmes for PwH in any context?’ Results: Out of 5.579 references, 36 studies were included, with 15 reported in a single source. Exercise frequency was mainly set at 3 days/week in primary studies, with a median of 2–4 days/week reported in systematic reviews. Training intensity was mainly defined by repetition maximum or maximum heart rate. Interventions generally lasted 6 weeks, with a median duration of 4–30 weeks in systematic reviews. Strengthening, flexibility, and aerobic exercise were the most common modalities, whereas endurance and proprioceptive training were rarely employed. Conclusions: Exercise dosages in this review align with current evidence for people with haemophilia, but individualised prescriptions remain critical to optimising health outcomes. Future research should prioritise standardised, evidence‐based protocols.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Acta Ortopedica Brasileira
- Vol. 34 (2)
EVALUATION OF THE RADIOISOTOPIC SYNOVECTOMY PROTOCOL IN PATIENTS WITH HEMOPHILIA
Introduction: Hemophilia is an inherited hemorrhagic disorder in which the most common musculoskeletal manifestation is intra-articular hemorrhage. Successive hemarthroses result in chronic synovitis, joint surface destruction, and chronic hemophilic arthropathy. When conservative treatment cannot halt an already established synovitis, removing the synovium may interrupt the process of joint destruction, and radioisotopic synovectomy (RS) becomes one of the treatments of choice. Objective: To evaluate the safety and effectiveness of the RS protocol in reducing the incidence of hemarthrosis in patients with hemophilia. Materials and Methods: This retrospective study is based on a review of medical records. We compared the number of bleeding events one year before and one year after RS. Results were submitted to statistical analysis and compared using the Wilcoxon signed-rank test. Results: 65 RS procedures were performed between 2008 and 2018 in patients followed at our institution. The number of bleeding events recorded in the joints submitted to intervention in the year preceding the procedure was 367. In contrast, the number in the following year was 203, a reduction of 44.68% (P<0.001). There were no complications related to the procedure during the analyzed period. Conclusion: The RS protocol was safe and effective in reducing the number of bleeding events. Level of Evidence IV; Case Series.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Acta Ortopedica Brasileira
- Vol. 34 (2)
Open AccessEVALUATION OF THE RADIOISOTOPIC SYNOVECTOMY PROTOCOL IN PATIENTS WITH HEMOPHILIA
Introduction: Hemophilia is an inherited hemorrhagic disorder in which the most common musculoskeletal manifestation is intra-articular hemorrhage. Successive hemarthroses result in chronic synovitis, joint surface destruction, and chronic hemophilic arthropathy. When conservative treatment cannot halt an already established synovitis, removing the synovium may interrupt the process of joint destruction, and radioisotopic synovectomy (RS) becomes one of the treatments of choice. Objective: To evaluate the safety and effectiveness of the RS protocol in reducing the incidence of hemarthrosis in patients with hemophilia. Materials and Methods: This retrospective study is based on a review of medical records. We compared the number of bleeding events one year before and one year after RS. Results were submitted to statistical analysis and compared using the Wilcoxon signed-rank test. Results: 65 RS procedures were performed between 2008 and 2018 in patients followed at our institution. The number of bleeding events recorded in the joints submitted to intervention in the year preceding the procedure was 367. In contrast, the number in the following year was 203, a reduction of 44.68% (P<0.001). There were no complications related to the procedure during the analyzed period. Conclusion: The RS protocol was safe and effective in reducing the number of bleeding events. Level of Evidence IV; Case Series.
- Open Access
- 20 December 2022
- Published by Associacao Brasileira de Medicina e Cirurgia do Tornozelo e Pe (ABTPe) in Journal of the Foot & Ankle
- Vol. 16 (3) , 259-263
Radiosynovectomy of the ankle in hemophilic arthropathy: effectiveness of samarium-153 and yttrium-90
Objective: Evaluate the effect of radiosynovectomy of the ankle with samarium-153 and yttrium-90 in hemophilic arthropathy through the possible reduction of hemarthrosis, analyzing complications, adverse effects, and the need for complementary therapies. Methods: Radiosynovectomy of the ankle in 15 hemophilic patients was analyzed retrospectively and followed between January 2008 and December 2021. The analysis was performed through patients’ medical records and diaries to quantify hemarthrosis that occurred six months before and six months after the procedure. Clinical follow-up and evaluation of outcomes were also analyzed. Results: Eighteen radiosynovectomies of the ankle were performed in 15 patients with a mean follow-up of 124 months. A reduction in episodes of haemarthrosis has been demonstrated within six months (pConclusion: The study demonstrated that radiosynovectomy of the ankle with samarium-153 and yttrium-90 in hemophilic patients is effective and safe. There was a decreased frequency of hemarthrosis, less need for complementary procedures, and no complications and adverse effects. Level of Evidence IV, Case Series.
- 20 December 2022
- Published by Associacao Brasileira de Medicina e Cirurgia do Tornozelo e Pe (ABTPe) in Journal of the Foot & Ankle
- Vol. 16 (3) , 259-263
Open AccessRadiosynovectomy of the ankle in hemophilic arthropathy: effectiveness of samarium-153 and yttrium-90
Objective: Evaluate the effect of radiosynovectomy of the ankle with samarium-153 and yttrium-90 in hemophilic arthropathy through the possible reduction of hemarthrosis, analyzing complications, adverse effects, and the need for complementary therapies. Methods: Radiosynovectomy of the ankle in 15 hemophilic patients was analyzed retrospectively and followed between January 2008 and December 2021. The analysis was performed through patients’ medical records and diaries to quantify hemarthrosis that occurred six months before and six months after the procedure. Clinical follow-up and evaluation of outcomes were also analyzed. Results: Eighteen radiosynovectomies of the ankle were performed in 15 patients with a mean follow-up of 124 months. A reduction in episodes of haemarthrosis has been demonstrated within six months (pConclusion: The study demonstrated that radiosynovectomy of the ankle with samarium-153 and yttrium-90 in hemophilic patients is effective and safe. There was a decreased frequency of hemarthrosis, less need for complementary procedures, and no complications and adverse effects. Level of Evidence IV, Case Series.
- 17 February 2021
- Published by Wiley in Haemophilia
- Vol. 27 (2) , e221-e229
Aquatic exercise in patients with haemophilia: Electromyographic and functional results from a prospective cohort study
Introduction: Recurrent joint bleeds in haemophilia patients often cause musculoskeletal changes leading to functional capacity impairment.Aim: In this study, we assessed the effects of aquatic activities performed to improve functional capacity in these patients.Methods: The interventional protocol consisted of 24 hydrotherapy sessions during three months, in comparison with 24 swimming sessions. The pre‐ and post‐intervention assessment consisted of Functional Independence Score, haemophilia joint health score (HJHS), Pediatric Haemophilia Activities List (PedHAL), surface electromyography (SEMG) of thigh muscles to assess muscle electric activity, and load cell on extensor and flexor thigh muscles to evaluate muscular strength.Results: Forty‐seven haemophilia patients were enrolled in this study, and 32 (23 severe haemophilia A, one moderate haemophilia A and 8 severe haemophilia B), median age 12y (6 to 40y), concluded the aquatic intervention. We observed a statistically significant increase with substantial improvement in functional capacity in the pre‐ and post‐intervention evaluation of hydrotherapy in comparison with the swimming protocol, with HJHS (p = .006 and p = .001 respectively), PedHAL (Sum score) (p = .022 and p = .001) and score FISH (p = .021). The swimming group revealed significant improvements in muscular strength, in all muscles tested (p = .005 and p = .001). SEMG signal amplitude reached significantly higher levels in all muscles evaluated after both interventions except for the vastus medialis (right) in the hydrotherapy group.Conclusion: Our results concluded that both swimming and hydrotherapy were associated with physical improvement in haemophilia patients; however, only hydrotherapy lead to a more significant improvement in functional capacity.
- 17 February 2021
- Published by Wiley in Haemophilia
- Vol. 27 (2) , e221-e229
Aquatic exercise in patients with haemophilia: Electromyographic and functional results from a prospective cohort study
Introduction: Recurrent joint bleeds in haemophilia patients often cause musculoskeletal changes leading to functional capacity impairment.Aim: In this study, we assessed the effects of aquatic activities performed to improve functional capacity in these patients.Methods: The interventional protocol consisted of 24 hydrotherapy sessions during three months, in comparison with 24 swimming sessions. The pre‐ and post‐intervention assessment consisted of Functional Independence Score, haemophilia joint health score (HJHS), Pediatric Haemophilia Activities List (PedHAL), surface electromyography (SEMG) of thigh muscles to assess muscle electric activity, and load cell on extensor and flexor thigh muscles to evaluate muscular strength.Results: Forty‐seven haemophilia patients were enrolled in this study, and 32 (23 severe haemophilia A, one moderate haemophilia A and 8 severe haemophilia B), median age 12y (6 to 40y), concluded the aquatic intervention. We observed a statistically significant increase with substantial improvement in functional capacity in the pre‐ and post‐intervention evaluation of hydrotherapy in comparison with the swimming protocol, with HJHS (p = .006 and p = .001 respectively), PedHAL (Sum score) (p = .022 and p = .001) and score FISH (p = .021). The swimming group revealed significant improvements in muscular strength, in all muscles tested (p = .005 and p = .001). SEMG signal amplitude reached significantly higher levels in all muscles evaluated after both interventions except for the vastus medialis (right) in the hydrotherapy group.Conclusion: Our results concluded that both swimming and hydrotherapy were associated with physical improvement in haemophilia patients; however, only hydrotherapy lead to a more significant improvement in functional capacity.
- 2 January 2021
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 35 (2) , 232-240
Knee radiosynovectomy with 153Sm-hydroxyapatite compared to 90Y-hydroxyapatite: initial results of a prospective trial
Introduction Radiosynovectomy (RS) with 90Y-hydroxyapatite (90Y-HyA) aims to control knee hemarthrosis in hemophiliac patients to prevent secondary arthropathy. However, knee RS using 153Sm-hydroxyapatite (153Sm-HyA) is considered less suitable due to the lower average soft tissue range and energy of 153Sm for large joints, such as the knees. Purpose The objective of this investigation was to assess the efficacy and safety of knee RS with 153Sm-HyA, compared to 90Y-HyA. Methods Forty patients were prospectively assigned to undergo knee RS with 153Sm-HyA (n = 19) or with 90Y-HyA (n = 21). The frequency of hemarthrosis episodes before and after treatment were compared. Results After six months of knee RS, 153Sm-HyA and 90Y-HyA promoted a similar reduction of hemarthrosis episodes (50% and 66.7%, respectively). However, after 12 months of knee RS, the reduction of hemarthrosis episodes was significantly (p = 0.037) higher using 153Sm-HyA (87.5%) compared to 90Y-HyA (50.0%). This discrepancy was more pronounced (p = 0.002) for 153Sm-HyA compared to 90Y-HyA in adults/adolescents. Conclusion Knee radiosynovectomy with 153Sm-HyA is safe, reduces hemarthrosis episodes after 12 months of treatments, especially in adults/adolescents and even with grades III/IV arthropathy, similar to 90Y-HyA. 90Y-HyA seems to promote better hemarthrosis control in small children.
- 2 January 2021
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 35 (2) , 232-240
Knee radiosynovectomy with 153Sm-hydroxyapatite compared to 90Y-hydroxyapatite: initial results of a prospective trial
Introduction Radiosynovectomy (RS) with 90Y-hydroxyapatite (90Y-HyA) aims to control knee hemarthrosis in hemophiliac patients to prevent secondary arthropathy. However, knee RS using 153Sm-hydroxyapatite (153Sm-HyA) is considered less suitable due to the lower average soft tissue range and energy of 153Sm for large joints, such as the knees. Purpose The objective of this investigation was to assess the efficacy and safety of knee RS with 153Sm-HyA, compared to 90Y-HyA. Methods Forty patients were prospectively assigned to undergo knee RS with 153Sm-HyA (n = 19) or with 90Y-HyA (n = 21). The frequency of hemarthrosis episodes before and after treatment were compared. Results After six months of knee RS, 153Sm-HyA and 90Y-HyA promoted a similar reduction of hemarthrosis episodes (50% and 66.7%, respectively). However, after 12 months of knee RS, the reduction of hemarthrosis episodes was significantly (p = 0.037) higher using 153Sm-HyA (87.5%) compared to 90Y-HyA (50.0%). This discrepancy was more pronounced (p = 0.002) for 153Sm-HyA compared to 90Y-HyA in adults/adolescents. Conclusion Knee radiosynovectomy with 153Sm-HyA is safe, reduces hemarthrosis episodes after 12 months of treatments, especially in adults/adolescents and even with grades III/IV arthropathy, similar to 90Y-HyA. 90Y-HyA seems to promote better hemarthrosis control in small children.
- 30 September 2020
- Published by Wiley in Haemophilia
- Vol. 26 (6) , E315-E322
Acupuncture as a therapeutic resource for treatment of chronic pain in people with haemophilia
Introduction: Chronic pain is common in individuals with severe and moderate haemophilia who did not receive prophylaxis during childhood.Objective: To verify the effectiveness of acupuncture in reducing intensity in chronic pain, changes in quality of life, joint function and impact on treatment satisfaction of haemophilia patients.Methods: Single‐blinded randomized clinical trial with 28 participants divided into two groups: Acupuncture (G1) treated with traditional unilateral acupuncture (side of greatest referred pain) and Control (G2) treated with transcutaneous electrical nerve stimulation (TENS), with electrodes on the joint of most intense pain. Both groups had a 20‐minute session per week, total of 05 consecutive sessions. Before starting treatment, participants underwent sociodemographic assessment, physical assessment (HJHS), quality of life questionnaire (Haem‐a‐Qol) and treatment expectation (Likert scale). After the end of the fifth session, Haem‐a‐Qol, HJHS and degree of satisfaction (Likert) were performed. The assessment of pain intensity using the visual analogue scale (VAS) was performed before the beginning and after the end of all sessions in both groups. Statistical analysis was performed using ANOVA, Bonferroni, t test and chi‐square test (P < .05).Results: There was a statistical difference within and between groups G1 and G2 in reduction of VAS. In Haem‐a‐Qol, the groups showed similarity in quality of life. Both groups had high expectations for treatment. G1 presented a better degree of treatment satisfaction than G2. Total HJHS showed no difference within and between groups. Conclusion: Acupuncture was effective in reducing pain intensity in haemophilia patients with chronic joint disease when compared to TENS.
- 30 September 2020
- Published by Wiley in Haemophilia
- Vol. 26 (6) , E315-E322
Acupuncture as a therapeutic resource for treatment of chronic pain in people with haemophilia
Introduction: Chronic pain is common in individuals with severe and moderate haemophilia who did not receive prophylaxis during childhood.Objective: To verify the effectiveness of acupuncture in reducing intensity in chronic pain, changes in quality of life, joint function and impact on treatment satisfaction of haemophilia patients.Methods: Single‐blinded randomized clinical trial with 28 participants divided into two groups: Acupuncture (G1) treated with traditional unilateral acupuncture (side of greatest referred pain) and Control (G2) treated with transcutaneous electrical nerve stimulation (TENS), with electrodes on the joint of most intense pain. Both groups had a 20‐minute session per week, total of 05 consecutive sessions. Before starting treatment, participants underwent sociodemographic assessment, physical assessment (HJHS), quality of life questionnaire (Haem‐a‐Qol) and treatment expectation (Likert scale). After the end of the fifth session, Haem‐a‐Qol, HJHS and degree of satisfaction (Likert) were performed. The assessment of pain intensity using the visual analogue scale (VAS) was performed before the beginning and after the end of all sessions in both groups. Statistical analysis was performed using ANOVA, Bonferroni, t test and chi‐square test (P < .05).Results: There was a statistical difference within and between groups G1 and G2 in reduction of VAS. In Haem‐a‐Qol, the groups showed similarity in quality of life. Both groups had high expectations for treatment. G1 presented a better degree of treatment satisfaction than G2. Total HJHS showed no difference within and between groups. Conclusion: Acupuncture was effective in reducing pain intensity in haemophilia patients with chronic joint disease when compared to TENS.